drugset / Trial / NCT01985087
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
Phase 1/2
Active not recruiting
18 enrolled
University of Louisville
James Graham Brown Cancer Center · collab
NaSingle-groupOpen-labelTreatment
Summary
In this study we propose to determine outcomes of patients age 70 or older treated with radiation over 2 weeks given with temozolomide 75 mg/m2 daily during radiotherapy and as a post radiation treatment of 150 mg/m2 - 200 mg /m2 for 6 cycles or until the disease progresses.
Timeline
- Start
- 2014-09
- Primary completion
- 2025-05
- Completion
- 2025-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | 150 mg/m2 | Oral |
| Subject | Temozolomide | Small molecule | 200 mg/m2 | Oral |